Denmark
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 29.09 B
|
Dec. 31, 2023 | USD 81.94 | -2.80% |
|
Denmark |
|
2 |
USD 2.41 B
|
Dec. 31, 2023 | USD 190.39 | -3.71% |
|
Denmark |
|
3 |
USD 2.28 B
|
Dec. 31, 2023 | USD 6.01 | -1.79% |
|
Denmark |
|
4 |
USD 670.05 M
|
Dec. 31, 2023 | USD 25.56 | -6.78% |
|
Denmark |
|
5 |
USD 441.87 M
|
Sept. 30, 2024 | USD 18.27 | -2.30% |
|
Denmark |
|
6 |
USD 245.39 M
|
Dec. 31, 2023 | USD 130.66 | 2.64% |
|
Denmark |
|
7 |
USD 47.90 M
|
Dec. 31, 2023 | USD 96.67 | -5.32% |
|
Denmark |
|
8 |
USD 17.01 M
|
Dec. 31, 2023 | USD 88.54 | -3.65% |
|
Denmark |
|
9 |
USD 5.99 M
|
Sept. 30, 2024 | USD 0.73 | -11.55% |
|
Denmark |
|
10 |
USD 2.99 M
|
Dec. 31, 2023 | USD 0.20 | -4.20% |
|
Denmark |
|
11 |
USD 1.16 M
|
Dec. 31, 2023 | USD 0.73 | 4.37% |
|
Denmark |
|
12 |
USD 859.26 K
|
Dec. 31, 2023 | USD 1.58 | -5.64% |
|
Denmark |
|
13 |
USD 637.43 K
|
Dec. 31, 2023 | USD 0.46 | -2.15% |
|
Denmark |
|
14 |
USD 335.88 K
|
Dec. 31, 2023 | USD 2.61 | -4.99% |
|
Denmark |
|
15 |
USD 72.89 K
|
Dec. 31, 2023 | USD 2.46 | -0.40% |
|
Denmark |
|
16 |
USD 62.61 K
|
Dec. 31, 2023 | USD 4.38 | -2.50% |
|
Denmark |
|
17 |
USD -3.47 K
|
Dec. 31, 2023 | USD 0.63 | -4.50% |
|
Denmark |
The Healthcare company in Denmark with the highest Gross Profit is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 29.09 B.
The Healthcare company in Denmark with the lowest Gross Profit is Initiator Pharma A/S (Stockholm Stock Exchange: INIT.ST) at USD -3.47 K.
The top 10 Healthcare companies in Denmark by Gross Profit are Novo Nordisk A/S, Genmab A/S, H. Lundbeck A/S, Bavarian Nordic A/S, Ambu A/S, Ascendis Pharma A/S, Zealand Pharma A/S, Gubra A/S, Scandinavian Medical Solutions A/S and BioPorto A/S.
The bottom 10 Healthcare companies in Denmark by Gross Profit are Initiator Pharma A/S, FluoGuide A/S, Evaxion Biotech A/S, ExpreS2ion Biotech Holding AB (publ), Danish Aerospace Company A/S, ViroGates A/S, Saniona AB (publ), BioPorto A/S, Scandinavian Medical Solutions A/S and Gubra A/S.